The addition of interacting antiarrhythmics to direct oral anticoagulants in patients with non-valvular atrial fibrillation may not increase ischemic stroke risk compared to non-interacting antiarrhythmics
1. In non-valvular atrial fibrillation (NVAF) patients taking direct oral anticoagulants (DOACs), adding amiodarone, diltiazem, dronedarone, or verapamil does not...


![Novel biodegradable sirolimus-eluting stents non-inferior to durable everolimus-eluting stents [BIOSCIENCE trial]](https://www.2minutemedicine.com/wp-content/uploads/2014/09/Taxus_stent_FDA-e1607803635904-350x250.jpg)






